- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Amgen Inc (AMGN)
230.98
+4.99(+2.21%)
- Volume:2,489,777
- Day's Range:227.74 - 231.87
- 52 wk Range:198.64 - 258.45
AMGN Overview
- Prev. Close
- 225.99
- Day's Range
- 227.74-231.87
- Revenue
- 26.32B
- Open
- 229.96
- 52 wk Range
- 198.64-258.45
- EPS
- 11.89
- Volume
- 2,489,777
- Market Cap
- 123.56B
- Dividend (Yield)
- 7.76(3.43%)
- Average Volume (3m)
- 2,609,600
- P/E Ratio
- 20.80
- Beta
- 0.56
- 1-Year Change
- 6.04%
- Shares Outstanding
- 534,930,850
- Next Earnings Date
- Nov 01, 2022
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.
Amgen Inc News
- The Key for Amgen is the 'Lack of a Black Box' - Mizuho
- ByInvesting.com-
By Sam Boughedda Amgen (NASDAQ:AMGN) was reiterated at Neutral with a $208 per share price target by a Mizuho analyst on Monday, despite the stock's decline during the session...
- Bristol-Myers Squibb Rallies as FDA's Approval of Sotyktu is a 'Best-case Scenario'
- ByInvesting.com-
By Senad Karaahmetovic Shares of Bristol-Myers Squibb (NYSE:BMY) are up about 7% in premarket Monday after the U.S. FDA approved Deucravacitinib, now known as Sotyktu, for the...
Amgen Inc Analysis
- Oil’s Iran Cliffhanger: What To Know And What To Expect
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
- 75 Firms Going Ex-Dividend Next Week, Including Target, Amgen And Chevron
- ByTalkmarkets-
Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to be eligible to receive its next dividend.
- What Happened This Week: AMTD Revives Meme Action, Alibaba Sparks Speculation
Just as the dog days of summer have very little to do with dogs and everything to do with heat, so went the first week of August in the markets. The emphasis was not on the dogs,...
Amgen Inc Company Profile
Amgen Inc Company Profile
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Read More
Analyst Price Target
| Average | 249.81 (+7.88% Upside) |
| High | 295 |
| Low | 182 |
| Price | 231.57 |
| No. of Analysts | 28 |
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Strong Buy | Sell | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Neutral |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Neutral |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 67.00 | 67.45 | 66.22 | +0.24 | +0.36% | 8.54M | Toronto | |||
| 85.45 | 85.94 | 83.20 | +1.05 | +1.24% | 3.26M | Toronto | |||
| 123.22 | 123.71 | 119.57 | +2.55 | +2.11% | 2.10M | Toronto | |||
| 57.41 | 57.77 | 56.81 | +0.13 | +0.23% | 739.75K | Toronto | |||
| 22.84 | 22.95 | 22.41 | +0.26 | +1.15% | 342.13K | Toronto | |||
| 27.40 | 27.43 | 26.77 | +0.41 | +1.52% | 184.82K | Toronto | |||
| 30.14 | 30.17 | 29.65 | +0.12 | +0.40% | 2.56M | Toronto | |||
| 54.74 | 54.92 | 54.25 | +0.02 | +0.04% | 1.24M | Toronto | |||
| 61.04 | 61.26 | 59.54 | +1.15 | +1.92% | 3.35M | Toronto | |||
| 22.14 | 22.19 | 21.65 | +0.36 | +1.65% | 555.40K | Toronto | |||
| 17.95 | 18.05 | 17.41 | +0.26 | +1.47% | 1.45M | Toronto | |||
| 15.82 | 15.97 | 15.56 | +0.03 | +0.19% | 1.80M | Toronto | |||
| 57.97 | 58.12 | 56.76 | +1.21 | +2.13% | 5.64M | Toronto | |||
| 6.31 | 6.56 | 6.31 | -0.3000 | -4.54% | 11.72K | TSXV | |||
| 33.26 | 33.61 | 33.12 | -0.04 | -0.12% | 509.02K | Toronto |